Vitamin D receptor FokI, BsmI, ApaI, and TaqI polymorphisms and susceptibility to ovarian cancer: a meta-analysis

References

• Ahn J, Albanes D, Berndt SI, et al. (2009). Vitamin D-related genes, serum vitamin D concentrations and prostate cancer risk. Carcinogenesis, 30, 769–76
   PubMed Web of Science ®Google Scholar
• Clendenen TV, Arslan AA, Koenig KL, et al. (2008). Vitamin D receptor polymorphisms and risk of epithelial ovarian cancer. Cancer Lett, 260, 209–15
   Google Scholar
• DerSimonian R, Laird N. (1986). Meta-analysis in clinical trials. Control Clin Trials, 7, 177–88
   PubMed Web of Science ®Google Scholar
• Egger M, Smith GD, Phillips AN. (1997a). Meta-analysis: Principles and procedures. BMJ, 315, 1533–7
   PubMed Web of Science ®Google Scholar
• Egger M, Smith GD, Schneider M, Minder C. (1997b). Bias in meta-analysis detected by a simple, graphical test. BMJ, 315, 629–34
   PubMed Web of Science ®Google Scholar
• Garland CF, Mohr SB, Gorham ED, et al. (2006). Role of ultraviolet B irradiance and vitamin D in prevention of ovarian cancer. Am J Prev Med, 31, 512–14
   PubMed Web of Science ®Google Scholar
• Higgins JP, Thompson SG. (2002). Quantifying heterogeneity in a meta-analysis. Stat Med, 21, 1539–58
   PubMed Web of Science ®Google Scholar
• Holick MF. (2006). Vitamin D: Its role in cancer prevention and treatment. Prog Biophys Mol Biol, 92, 49–59
   PubMed Web of Science ®Google Scholar
• Hunn J, Rodriguez GC. (2012). Ovarian cancer: Etiology, risk factors, and epidemiology. Clin Obstet Gynecol, 55, 3–23
   PubMed Web of Science ®Google Scholar
• Kostner K, Denzer N, Muller CS, et al. (2009). The relevance of vitamin D receptor (VDR) gene polymorphisms for cancer: A review of the literature. Anticancer Res, 29, 3511–36
   PubMed Web of Science ®Google Scholar
• Lee YH, Ji JD, Song GG. (2007). Tumor necrosis factor-alpha promoter -308 A/G polymorphism and rheumatoid arthritis susceptibility: A metaanalysis. J Rheumatol, 34, 43–9
   Google Scholar
• Lee YH, Witte T, Momot T, et al. (2005). The mannose-binding lectin gene polymorphisms and systemic lupus erythematosus: Two case-control studies and a meta-analysis. Arthritis Rheum, 52, 3966–74
   PubMed Web of Science ®Google Scholar
• Leitao MM Jr, Boyd J, Hummer A, et al. (2004). Clinicopathologic analysis of early-stage sporadic ovarian carcinoma. Am J Surg Pathol, 28, 147–59
   Google Scholar
• Lurie G, Wilkens LR, Thompson PJ, et al. (2011). Vitamin D receptor rs2228570 polymorphism and invasive ovarian carcinoma risk: Pooled analysis in five studies within the Ovarian Cancer Association Consortium. Int J Cancer, 128, 936–43
   Google Scholar
• Lurie G, Wilkens LR, Thompson PJ, et al. (2007). Vitamin D receptor gene polymorphisms and epithelial ovarian cancer risk. Cancer Epidemiol Biomarkers Prev, 16, 2566–71
   PubMed Web of Science ®Google Scholar
• Maruotti N, Cantatore FP. (2010). Vitamin D and the immune system. J Rheumatol, 37, 491–5
   PubMed Web of Science ®Google Scholar
• Miyamoto K, Kesterson RA, Yamamoto H, et al. (1997). Structural organization of the human vitamin D receptor chromosomal gene and its promoter. Mol Endocrinol, 11, 1165–79
   PubMed Web of Science ®Google Scholar
• Morrison NA, Yeoman R, Kelly PJ, Eisman JA. (1992). Contribution of trans-acting factor alleles to normal physiological variability: Vitamin D receptor gene polymorphism and circulating osteocalcin. Proc Natl Acad Sci USA, 89, 6665–9
   PubMed Web of Science ®Google Scholar
• Mostowska A, Sajdak S, Pawlik P, et al. (2013). Vitamin D receptor gene BsmI and FokI polymorphisms in relation to ovarian cancer risk in the Polish population. Genet Test Mol Biomarkers, 17, 183–7
   Google Scholar
• Nath SK, Harley JB, Lee YH. (2005). Polymorphisms of complement receptor 1 and interleukin-10 genes and systemic lupus erythematosus: A meta-analysis. Hum Genet, 118, 225–34
   PubMed Web of Science ®Google Scholar
• Peters U, Hayes RB, Chatterjee N, et al. (2004). Circulating vitamin D metabolites, polymorphism in vitamin D receptor, and colorectal adenoma risk. Cancer Epidemiol Biomarkers Prev, 13, 546–52
   PubMed Web of Science ®Google Scholar
• Tamez S, Norizoe C, Ochiai K, et al. (2009). Vitamin D receptor polymorphisms and prognosis of patients with epithelial ovarian cancer. Br J Cancer, 101, 1957–60
   Google Scholar
• Tworoger SS, Gates MA, Lee IM, et al. (2009). Polymorphisms in the vitamin D receptor and risk of ovarian cancer in four studies. Cancer Res, 69, 1885–91
   Google Scholar
• Villena-Heinsen C, Meyberg R, Axt-Fliedner R, et al. (2002). Immunohistochemical analysis of 1,25-dihydroxyvitamin-D3-receptors, estrogen and progesterone receptors and Ki-67 in ovarian carcinoma. Anticancer Res, 22, 2261–7
   PubMed Web of Science ®Google Scholar